Rights and permissions
About this article
Cite this article
Shifting costs to beneficiaries may not save costs in long run. Pharmacoecon. Outcomes News 640, 2 (2011). https://doi.org/10.2165/00151234-201106400-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201106400-00005